Anlon Healthcare board approves stock split, bonus issue; shares rise 7%

The stock advanced as much as 6.89% to ₹118.72 on the National Stock Exchange (NSE). At 1:50 pm, it was up 5.52% to ₹117.19.

The scrip has risen 7.81% in the past week. However, it has declined 7.22% over the month and 21.12% on the year-to-date basis.

While the share hit a 52-week high of ₹172.75 on November 28, 2025, it touched a year’s low of ₹90.78 apiece on September 3, 2025.

Anlon Healthcare board approves stock split, bonus issue

In an exchange filing on Friday, the company said that its board has approved stock split of one equity share with a face value of ₹10 into five shares having a face value of ₹2. The record date for the same will be determined later.

The company's board also approved the issue of bonus shares in the ratio of 1:1, which means one bonus share having a face value of ₹2 for every two shares of ₹2 each fully paid-up held by shareholders on the record date, which will be announced later.

The company also approved an increase in authorised share capital and a consequent alteration to the capital clause of the Memorandum of Association.

The board, according to a regulatory filing, gave thumbs up to "increase the authorised share capital of the company from ₹55,00,00,000/-, divided into 27,50,00,000 equity shares of ₹2/- each, to ₹1,10,00,00,000/- by creation of additional equity shares to the tune of 27,50,00,000 equity shares of ₹2/- each, aggregating to 55,00,00,000 equity shares of ₹2/- each, subject to approval of the Members of the Company and other applicable statutory approvals, if any."